ibrutinib,rituximab
abbvie,janssen
[]
ibrutinib induction/maintenance is highly effective for mcl #ash22
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more